協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/02/03 | 2,280 | 2,281.5 | 2,224 | 2,229.5 | -90.5 | -3.9% | 1,229,800 |
| 2025/01/31 | 2,335 | 2,336.5 | 2,300 | 2,320 | -26.5 | -1.1% | 1,019,200 |
| 2025/01/30 | 2,328 | 2,354.5 | 2,318 | 2,346.5 | +18.5 | +0.8% | 646,800 |
| 2025/01/29 | 2,328.5 | 2,335.5 | 2,316 | 2,328 | -0.5 | ±0% | 540,600 |
| 2025/01/28 | 2,335 | 2,339.5 | 2,315.5 | 2,328.5 | +4.5 | +0.2% | 666,100 |
| 2025/01/27 | 2,343.5 | 2,353 | 2,319 | 2,324 | +10 | +0.4% | 633,300 |
| 2025/01/24 | 2,313 | 2,337.5 | 2,309.5 | 2,314 | +22 | +1% | 646,800 |
| 2025/01/23 | 2,274 | 2,295 | 2,257.5 | 2,292 | +4.5 | +0.2% | 696,400 |
| 2025/01/22 | 2,280 | 2,296.5 | 2,275.5 | 2,287.5 | +3.5 | +0.2% | 569,300 |
| 2025/01/21 | 2,299 | 2,301.5 | 2,275.5 | 2,284 | -10 | -0.4% | 345,800 |
| 2025/01/20 | 2,285 | 2,297 | 2,282 | 2,294 | +9 | +0.4% | 322,900 |
| 2025/01/17 | 2,283 | 2,295.5 | 2,275 | 2,285 | +2.5 | +0.1% | 656,100 |
| 2025/01/16 | 2,321.5 | 2,323 | 2,282.5 | 2,282.5 | -37 | -1.6% | 813,900 |
| 2025/01/15 | 2,356 | 2,361 | 2,317.5 | 2,319.5 | -10.5 | -0.5% | 792,600 |
| 2025/01/14 | 2,303.5 | 2,342 | 2,291.5 | 2,330 | +40 | +1.7% | 1,243,900 |
| 2025/01/10 | 2,310 | 2,319.5 | 2,283.5 | 2,290 | -30 | -1.3% | 962,300 |
| 2025/01/09 | 2,307 | 2,330 | 2,296.5 | 2,320 | +6 | +0.3% | 877,200 |
| 2025/01/08 | 2,331.5 | 2,337 | 2,314 | 2,314 | -17.5 | -0.8% | 778,600 |
| 2025/01/07 | 2,334 | 2,343 | 2,325.5 | 2,331.5 | +5 | +0.2% | 718,400 |
| 2025/01/06 | 2,374 | 2,385 | 2,317.5 | 2,326.5 | -49 | -2.1% | 1,077,200 |
| 2024/12/30 | 2,384.5 | 2,396 | 2,371 | 2,375.5 | -9 | -0.4% | 679,900 |
| 2024/12/27 | 2,362 | 2,391.5 | 2,360 | 2,384.5 | -4 | -0.2% | 833,300 |
| 2024/12/26 | 2,370 | 2,388.5 | 2,369.5 | 2,388.5 | +9 | +0.4% | 825,600 |
| 2024/12/25 | 2,390 | 2,393 | 2,369 | 2,379.5 | -6.5 | -0.3% | 519,100 |
| 2024/12/24 | 2,395 | 2,396.5 | 2,380 | 2,386 | +1.5 | +0.1% | 345,200 |
| 2024/12/23 | 2,390 | 2,392.5 | 2,366 | 2,384.5 | +9 | +0.4% | 465,100 |
| 2024/12/20 | 2,397.5 | 2,404.5 | 2,373.5 | 2,375.5 | -17 | -0.7% | 969,300 |
| 2024/12/19 | 2,370 | 2,401 | 2,369 | 2,392.5 | +10.5 | +0.4% | 682,300 |
| 2024/12/18 | 2,393 | 2,402.5 | 2,372.5 | 2,382 | -15 | -0.6% | 704,000 |
| 2024/12/17 | 2,385 | 2,417 | 2,385 | 2,397 | +12 | +0.5% | 1,063,200 |
| 2024/12/16 | 2,410 | 2,426.5 | 2,373 | 2,385 | -28 | -1.2% | 1,091,400 |
| 2024/12/13 | 2,433 | 2,456 | 2,413 | 2,413 | -43.5 | -1.8% | 1,341,800 |
| 2024/12/12 | 2,466 | 2,473 | 2,453 | 2,456.5 | -7.5 | -0.3% | 1,205,900 |
| 2024/12/11 | 2,491.5 | 2,501 | 2,451.5 | 2,464 | -19 | -0.8% | 1,068,700 |
| 2024/12/10 | 2,532 | 2,532 | 2,464 | 2,483 | -25 | -1% | 970,200 |
| 2024/12/09 | 2,474.5 | 2,536 | 2,474.5 | 2,508 | +50 | +2% | 1,349,400 |
| 2024/12/06 | 2,446 | 2,467 | 2,425.5 | 2,458 | +14.5 | +0.6% | 1,115,300 |
| 2024/12/05 | 2,461.5 | 2,468.5 | 2,443.5 | 2,443.5 | -1.5 | -0.1% | 1,223,400 |
| 2024/12/04 | 2,461 | 2,486.5 | 2,430.5 | 2,445 | -52.5 | -2.1% | 1,169,400 |
| 2024/12/03 | 2,479 | 2,514 | 2,467 | 2,497.5 | +19 | +0.8% | 1,171,100 |
| 2024/12/02 | 2,495.5 | 2,500 | 2,460.5 | 2,478.5 | -7.5 | -0.3% | 924,800 |
| 2024/11/29 | 2,467 | 2,502.5 | 2,466 | 2,486 | -18 | -0.7% | 721,900 |
| 2024/11/28 | 2,479 | 2,508.5 | 2,466 | 2,504 | +18 | +0.7% | 1,351,600 |
| 2024/11/27 | 2,480 | 2,506.5 | 2,469.5 | 2,486 | +16.5 | +0.7% | 946,600 |
| 2024/11/26 | 2,484 | 2,512 | 2,455 | 2,469.5 | -33 | -1.3% | 1,231,900 |
| 2024/11/25 | 2,560 | 2,560 | 2,502.5 | 2,502.5 | -20.5 | -0.8% | 2,980,400 |
| 2024/11/22 | 2,538 | 2,546.5 | 2,511 | 2,523 | -22 | -0.9% | 1,201,400 |
| 2024/11/21 | 2,600 | 2,633 | 2,543.5 | 2,545 | +17 | +0.7% | 1,858,400 |
| 2024/11/20 | 2,559.5 | 2,585 | 2,517 | 2,528 | -29.5 | -1.2% | 1,522,700 |
| 2024/11/19 | 2,593.5 | 2,598.5 | 2,557 | 2,557.5 | -15.5 | -0.6% | 982,100 |
101～
150
件表示中 / 3732件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 243,700円 | -3.5% | -11.3% | 2.46% | 22.38倍 | 1.50倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 139,100円 | +0.9% | +380.2% | 5.61% | 19.16倍 | 1.65倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 254,800円 | +20.9% | +10.6% | 2.59% | 12.04倍 | 1.59倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 407,300円 | +0.1% | -3.4% | 3.93% | 27.69倍 | 1.36倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 153,900円 | +0.6% | +43.3% | 5.20% | 10.79倍 | 0.93倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
